Transcatheter aortic valve implantation (TAVI) has recently emerged as a treatment option for high risk patients with severe symptomatic aortic stenosis and has now been performed in more than 20,000 patients. This article provides an overview on TAVI with a special focus on the technical aspects when using the transfemoral approach. The following is an introduction and summary of the complete unabridged version, supplemented with extensive moving imagery, which can be viewed at www.eurointervention.org.
Two devices are commercially available:
The balloon expandable Edwards SAPIEN XTTM transcatheter heart valve (ES; Edwards Lifesciences, Irvine, CA ...
1. CHU Bichat–Claude Bernard, AP-HP, Paris, France; 2. St George Hospital, London, UK
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
Read next articleThe EuroIntervention bifurcation supplement